ADILADIAL PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ADIAL PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADILEsta | $13M#7 | — | — | — | — | 39.5%#6 | — | — | — | — | -46.7%#4 | — |
| REVB | $16M#1 | 0.1x#3 | 1.6x#7 | — | — | 40.7%#5 | — | -88.5%#3 | — | — | -88.5%#10 | — |
| MRKR | $16M#2 | — | 1.3x#5 | 4.4x#2 | -46.2%#5 | -13.3%#8 | -363.5%#1 | -100.0%#4 | -1413.6%#3 | — | -6.4%#2 | — |
| CTXR | $15M#3 | — | 0.2x#1 | 169.7x#7 | 0.0%#4 | -0.8%#7 | -42806.2%#7 | -59.7%#2 | — | — | -64.3%#7 | — |
| MTNB | $15M#4 | — | 8.1x#11 | 13.3x#3 | -65.6%#6 | 57.3%#2 | -635.0%#3 | -574.7%#11 | — | — | — | — |
| AEON | $15M#5 | — | — | — | — | -193.4%#12 | — | — | — | — | -65.5%#8 | — |
| ALLR | $14M#6 | 0.0x#1 | 3.9x#9 | 42.6x#6 | — | 54.2%#3 | -3939.1%#5 | -317.6%#9 | — | — | -40.9%#3 | — |
| RKTO | $13M#8 | — | 1.6x#6 | — | — | -52.3%#10 | — | -152.0%#6 | — | — | -63.7%#6 | — |
| KAPA | $13M#9 | — | 3.0x#8 | — | — | -109.3%#11 | — | -130.0%#5 | — | — | -93.1%#11 | — |
| BOLT | $13M#10 | — | 1.0x#3 | 1.6x#1 | 0.1%#3 | 47.1%#4 | -469.3%#2 | -264.1%#8 | — | — | 11.1%#1 | — |
| KTTA | $12M#11 | — | 0.2x#2 | 25.4x#4 | 3130.4%#1 | -46.9%#9 | -4286.7%#6 | -41.0%#1 | — | — | -53.8%#5 | — |
| HIND | $12M#12 | 0.0x#2 | 4.9x#10 | 38.6x#5 | 24.4%#2 | -609.0%#13 | -3269.4%#4 | -405.7%#10 | -226.2%#2 | — | -68.6%#9 | — |
| PPCB | $12M#13 | — | 1.3x#4 | — | — | 68.0%#1 | — | -200.6%#7 | -176.3%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice